Efficacy and safety of transoral incisionless fundoplication in non-obese and obese adults: a population-based cohort study from the United States - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Effectiveness and safety of transoral incisionless fundoplication in adults with varying body weights: findings from a U.S. population-based cohort study

  • By

  • Fouad Jaber

  • Saltenat Moghaddam Adames

  • Mohamed Jaber

  • Kinan Obiedat

  • Kalpesh Patel

  • Teminioluwa A. Ajayi

  • Roy Tomas DaVee

  • Fares W. Ayoub

  • Nirav Thosani

  • Wasseem Skef

  • July 2, 2026

Share

Clinical Scorecard: Effectiveness and safety of transoral incisionless fundoplication in adults with varying body weights: findings from a U.S. population-based cohort study

At a Glance

Category

Detail

Condition

Gastroesophageal reflux disease (GERD)

Key Mechanisms

Transoral incisionless fundoplication (TIF) repairs the anti-reflux barrier via flap valve reconstruction, restoring the angle of His, and augmenting the high-pressure zone at the lower esophageal sphincter.

Target Population

Adults aged ≥ 18 years with chronic symptomatic GERD

Care Setting

U.S. population-based cohort study using electronic medical records

Key Highlights

  • TIF is effective for patients with axial hernia < 2 cm or hiatus diameters < 3 cm.

  • TIF has comparable efficacy to surgical fundoplication in appropriately selected patients.

  • BMI ≥ 35 kg/m2 is a relative contraindication for TIF.

  • Class 1 obesity (BMI 30–34.9 kg/m2) represents a significant cohort of GERD patients.

  • Combining TIF with cruroplasty shows comparable short-term efficacy and excellent safety.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of GERD should be confirmed using validated ICD-10 codes.

Management

  • Consider TIF for patients with axial hernia < 2 cm or hiatus diameters < 3 cm.

Monitoring & Follow-up

  • Monitor for postoperative new PPI recidivism and incidence of post-TIF esophagitis.

Risks

  • Higher fundoplication failure rates with increasing BMI and potential for perioperative complications.

Patient & Prescribing Data

Adults with GERD stratified by BMI: non-obese (BMI < 30 kg/m2) and class I obesity (BMI 30–34.9 kg/m2).

TIF may be effective in class I obesity, but BMI ≥ 35 kg/m2 is a contraindication.

Clinical Best Practices

  • Perform one-to-one propensity score matching to minimize confounding.

  • Assess covariate balance post-matching to ensure comparability between BMI cohorts.

Related Resources & Content

  1. Obesity Surgery, 2025 -- Surgical Options for Managing GERD in Individuals with Moderate Obesity: Comparing Fundoplication and Roux-en-Y Gastric Bypass

  2. Journal of Gastrointestinal Surgery, 2021 -- Laparoscopic Fundoplication Demonstrates Efficacy in Treating Gastroesophageal Reflux in Patients with Impaired Esophageal Motility

  3. Obesity Surgery, 2025 -- Safety Profiles of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Prior Fundoplication: An Analysis of 499 Cases from MBSAQIP

  4. ASGE guideline on the diagnosis and management of GERD: summary and recommendations

  5. Obesity Surgery — Factors Influencing the Effectiveness of Endoscopic Sleeve Gastroplasty

  6. ASGE | American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: summary and recommendations

  7. Transoral Incisionless Fundoplication Effective in Eliminating GERD Symptoms in Partial Responders to Proton Pump Inhibitor Therapy at 6 Months: The TEMPO Randomized Clinical Trial - PMC

  8. Does Transoral Incisionless Fundoplication (TIF. 2.0) Improve Atypical GERD Symptoms? A Systematic Review and Meta-Analysis - PMC

Original Source(s)

Related Content